In Vitro Efficacy of Brincidofovir against Variola Virus [PDF]
ABSTRACT Brincidofovir (CMX001), a lipid conjugate of the acyclic nucleotide phosphonate cidofovir, is under development for smallpox treatment using “the Animal Rule,” established by the FDA in 2002. Brincidofovir reduces mortality caused by orthopoxvirus infection in animal models.
Victoria A, Olson +7 more
openaire +2 more sources
Clinical Features Present, Past & Future Prospective of Monkey Pox: A Orthopoxvirus [PDF]
Some issues regarding the potential spread of monkeypox have arisen just as the international world is beginning to recover from the initial alarm that was caused by the probable spread of coronavirus disease 2019 (COVID-19).
Kumar, Roshan +6 more
core +2 more sources
Monkeypox – An emerging pandemic
Monkeypox–a zoonotic disease caused by the monkeypox virus, an orthopoxviruses family member. Recently monkeypox cases are increasing at an alarming rate in the US and worldwide.
Kunal M. Ajmera +3 more
doaj +1 more source
Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: a single-arm open-label phase I clinical trial [PDF]
BACKGROUND: Opportunistic infections including cytomegalovirus (CMV) are a major cause of morbidity and mortality in solid organ transplant (SOT) recipients.
Beagley, Leone +13 more
core +1 more source
Clinical Features, Antiviral Treatment, and Patient Outcomes:A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks [PDF]
Background:This study aims to comparatively analyze clinical features, treatment, and patient outcomes between the previous and the 2022 mpox (monkeypox) outbreaks.
Avan, Amine +7 more
core +2 more sources
The race for Ebola drugs: pharmaceuticals, security and global health governance [PDF]
The international Ebola response mirrors two broader trends in global health governance: (1) the framing of infectious disease outbreaks as a security threat; and (2) a tendency to respond by providing medicines and vaccines.
Anne Roemer-Mahler +42 more
core +1 more source
Brincidofovir (CMX001) Inhibits BK Polyomavirus Replication in Primary Human Urothelial Cells [PDF]
ABSTRACTBK polyomavirus (BKPyV)-associated hemorrhagic cystitis (PyVHC) complicates 5 to 15% of allogeneic hematopoietic stem cell transplantations. Targeted antivirals are still unavailable. Brincidofovir (BCV; previously CMX001) has shown inhibitory activity against diverse viruses, including BKPyV in a primary human renal tubule cell culture model ...
Garth D. Tylden +2 more
openaire +3 more sources
Is photodynamic therapy with curcumin suitable for combating monkeypox?
Monkeypox (MPX) is a zoonotic viral infection caused by the Monkeypox Virus (MPXV), which may spread person-to-person directly. It is currently being treated with previously intended drugs for smallpox or other diseases caused by the orthopoxvirus, such
Siu Kan Law
doaj +1 more source
Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection
Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report four pediatric HCT recipients with d-ADV treated successfully with BCV.
Shuk Ying Chan +4 more
openaire +2 more sources
Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease
In May 2022, a new global outbreak of mpox (formerly, human monkeypox) emerged that was declared a public health emergency of international concern by the World Health Organization on July 23, 2022.
Sharon Sukhdeo +2 more
doaj +1 more source

